In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 145589-03-3, name is (R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one, introducing its new discovery. Synthetic Route of 145589-03-3
Organoaluminum chlorides react smoothly with alpha,beta-unsaturated N-acyloxazolidinones providing chiral beta-branched carboxylic acid derivatives.An unexpected contrast between the mode of reaction of dimethylaluminum chloride and that of the higher homologues is observed.While diethylaluminum chloride and its higher homologues react with the acceptors at low temperature via a polar pathway, dimethylaluminum chloride requires activation by UV-light or radical initiation under otherwise identical conditions.With bicyclic oxazolidinones derived from galactosamine a high stereoselection is accomplished in the formation of the branched carboxylic acid derivative.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 145589-03-3, and how the biochemistry of the body works.Synthetic Route of 145589-03-3
Reference：
Oxazolidine – Wikipedia,
Oxazolidine | C3H2610NO – PubChem